RxDoctor Payments Data

Carla Williams

Psychiatric/Mental Health · New York, NYNPI 1992211577

Payments from drug & device makers

$7,934in general payments, 2019–2025

Across 380 payments — averaging $20.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Teva Pharmaceuticals USA, Inc.$1K
  • Lundbeck LLC$1000
  • Alkermes, Inc.$980
  • E.r. Squibb & Sons, L.L.C.$726
  • Johnson & Johnson$579
  • plus $2K from 11 others

What the payments were for

  • Food & beverage$7,57896%
  • Education$3564%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,934 in reported general payments places this provider in the 95th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate61$154,706
VraylarCariprazine Hcl76$106,310
RexultiBrexpiprazole45$64,030
TrintellixVortioxetine Hydrobromide36$20,044
Aripiprazole177$7,185
QuviviqDaridorexant Hcl14$6,593
Lurasidone Hcl29$6,370
Asenapine Maleate11$2,582
Bupropion XlBupropion Hcl133$1,868
Quetiapine Fumarate180$1,779
Mirtazapine113$1,525
Eszopiclone13$1,432
Atomoxetine Hcl11$1,195
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine16$1,115
Chlorpromazine Hcl16$980

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$579$154,70661 claims
AbbVieVraylar$1,674$106,31076 claims
Otsuka America Pharmaceutical, Inc.Rexulti$462$64,03045 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$27$20,04436 claims
Idorsia Pharmaceuticals US IncQuviviq$20$6,59314 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,385 psychiatric/mental health providers in New York.

Other psychiatric/mental health in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →